Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Clinical Calcium|June 30, 2010
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of cinacalcet in the treatment of CKD-MBD]Fumihiko Koiwa, Yuichi MarutaBlood Purification|September 8, 2015
Clinical Expectation of Online Hemodiafiltration: A Japanese PerspectiveTadao Akizawa, Fumihiko KoiwaClinical Calcium|December 4, 2004
[Significance of point of no return in therapeutic strategy for treatment of renal osteodystrophy; from histopathological findings]Fumihiko Koiwa, Makoto HiroseClinical Calcium|May 2, 2007
[Indication of parathyroid intervention]Fumihiko Koiwa, Takeshi HasegawaClinical Calcium|February 3, 2009
[Management of phosphate in chronic kidney disease--Chemistry and history of phosphate binder]Fumihiko Koiwa, Yoshinori SatoClinical and Experimental Nephrology|July 9, 2016
Dose-response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II studyFumihiko Koiwa, Akira TeraoClinical and Experimental Nephrology|November 30, 2016
Management of phosphorus load in CKD patientsYutaka Taketani, Fumihiko Koiwa, Keitaro YokoyamaTherapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 10, 2018
Secondary Hyperparathyroidism: Pathogenesis and Latest TreatmentMasahide Mizobuchi, Hiroaki Ogata, Fumihiko KoiwaSeminars in Dialysis|June 18, 2018
Anemia in conventional hemodialysis: Finding the optimal treatment balanceTakeshi Hasegawa, Fumihiko Koiwa, Tadao AkizawaKidney International Reports|January 18, 2018
Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis PatientsFumihiko Koiwa, Keitaro Yokoyama, Masafumi Fukagawa, et al.Pageof 10